Contraindications. Active pathological bleeding. Mechanical prosthetic heart valve. Pradaxa Boxed Warnings. Boxed Warning. Premature discontinuation of Pradaxa
CONTRAINDICATIONS. PRADAXA is contraindicated in patients with: active pathological bleeding; history of a serious hypersensitivity reaction to dabigatran, dabigatran etexilate, or to one of the excipients of PRADAXA (e.g, anaphylactic reaction or anaphylactic shock);
CONTRAINDICATIONS PRADAXA is contraindicated in patients with: active pathological bleeding;; known serious hypersensitivity reaction (e.g.
Drugs during use may occur drug interactions when combined with Pradaxa 110mg: Interaction P - glycoprotein. P-gp inhibitors. Contraindicated to use Pradaxa
Notably in the prescribing information for both Multaq (dronedarone) and Pradaxa (dabigatran etexilate), the combination is not contraindicated
CONTRAINDICATIONS PRADAXA is contraindicated in patients with: - active pathological bleeding; - known serious hypersensitivity reaction (e.g, anaphylactic reaction or anaphylactic shock) to PRADAXA; - mechanical prosthetic heart valve. WARNINGS PRECAUTIONS Increased Risk of Thrombotic Events after Premature Discontinuation
Pradaxa (dabigatran) is a brand-name drug used to decrease your risk of developing a blood clot. Learn about side effects, dosage, reversal of bleeds, and more. Contraindications. Pradaxa is
Drugs during use may occur drug interactions when combined with Pradaxa 110mg: Interaction P - glycoprotein. P-gp inhibitors. Contraindicated to use Pradaxa
4 CONTRAINDICATIONS . PRADAXA is contraindicated in patients with: Active pathological bleeding [see Warnings and Precautions (5.1) and Adverse Reactions (6.1)]. History of a serious hypersensitivity reaction to PRADAXA (e.g, anaphylactic reaction or anaphylactic shock) [see Adverse Reactions (6.1)]. 5 WARNINGS AND PRECAUTIONS
Comments